Skip to main content

Table 3 Agreement between SMR01 and case note review recorded comorbidity

From: Approaches to ascertaining comorbidity information: validation of routine hospital episode data with clinician-based case note review

 

Prevalence

    

Co-morbidity

SMRO1

CNR

Kappa*

Sensitivity

Specificity

PPV

NPV

 

n

%

n

%

Value

Label

%

95% CI

%

95% CI

%

95% CI

%

95% CI

Ischaemic heart disease

1146

35.6

1277

39.7

0.63

Substantial

72.8

(70.3-75.2)

88.9

(87.4-90.2)

81.2

(78.8-83.3)

83.3

(81.6-84.8)

Hypertension

928

28.8

1715

53.3

0.28

Fair

42.4

(40.1-44.8)

86.7

(84.9-88.3)

78.4

(75.7-81.0)

56.9

(54.9-58.9)

Cerebrovascular disease

282

8.8

248

7.7

0.80

Substantial

87.1

(82.4-90.7)

97.8

(97.2-98.3)

76.6

(71.3-81.2)

98.9

(98.5-99.2)

Peripheral vascular

250

7.8

379

11.8

0.39

Fair

36.9

(32.2-41.9)

96.1

(95.4-96.8)

56.0

(49.8-62.0)

92.0

(90.9-92.9)

Congestive cardiac failure

511

15.9

546

17.0

0.45

Moderate

52.4

(48.2-56.5)

91.6

(90.5- 92.6)

56.0

(51.6-60.2)

90.4

(89.2-91.5)

Diabetes mellitus

501

15.6

805

25.0

0.65

Substantial

58.4

(54.9-61.7)

98.7

(98.2-99.1)

93.8

(91.4-95.6)

87.7

(86.4-88.9)

Dementia

91

2.8

187

5.8

0.38

Fair

29.9

(23.8-36.9)

98.8

(98.4-99.2)

61.5

(51.3-70.9)

95.8

(95.1-96.5)

Chronic obstructive pulmonary disease

255

7.9

283

8.8

0.51

Moderate

52.7

(46.8-58.4)

96.4

(95.7-97.0)

58.4

(52.3-64.3)

95.5

(94.7-96.2)

Connective tissue disease

140

4.3

154

4.8

0.54

Moderate

53.9

(46.0-61.6)

98.1

(97.6-98.6)

59.3

(51.0. 67.1)

97.7

(97.1-98.2)

Haematological malignancy

39

1.2

78

2.4

0.57

Moderate

43.6

(33.1 . 54.6)

99.8

(99.6-99.9)

87.2

(73.3-94.4)

98.6

(98.1-99.0)

Non-haematological malignancy

300

9.3

454

14.1

0.51

Moderate

47.1

(42.6-51.7)

96.9

(96.2-97.5)

71.3

(66.0-76.2)

91.8

(90.7-92.7)

Chronic liver disease

37

1.1

33

1.0

0.51

Moderate

54.5

(38.0-70.2)

99.4

(99.1-99.6)

48.6

(33.4-64.1)

99.5

(99.2-99.7)

Current or ex-smoker

21

0.7

1564

48.6

0.01

Poor

1.1

(0.7-1.7)

99.8

(99.4-99.9)

81.0

(60.0-92.3)

51.6

(49.9-53.4)

  1. SMRO1. Scottish Morbidity Record 01; PPV, Positive Predictive Value; NPV, Negative Predictive Value; CI, Confidence Interval.
  2. *Interpretation of kappa: Agreement poor if κ ≤ 0.20, fair if 0.21κ ≤ O.40, moderate if 0.41κ ≤ 0.60, substantial if 0.61 ≤ 0.80 and good if κ > 0.80.